These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2281698)

  • 21. [Delayed sulfonylurea resistance in non-insulin-dependent diabetes mellitus].
    Farkas K; Jermendy G; Somogyi A
    Orv Hetil; 1997 Nov; 138(48):3031-5. PubMed ID: 9441264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roundtable. Blueprint for conversion of patients on metformin and sulfonylurea to Glucovance.
    Roselli A; Hayes JD; Seidner R; Marchione V; Snyder CM; Mayes K; Stiernberg CM; Milgram L
    Manag Care; 2001 Feb; 10(2 Suppl):17-21. PubMed ID: 11729404
    [No Abstract]   [Full Text] [Related]  

  • 23. Glycaemic control in type 2 diabetes.
    Campbell A
    Clin Evid; 2005 Dec; (14):474-90. PubMed ID: 16620416
    [No Abstract]   [Full Text] [Related]  

  • 24. [Possibilities and limits of oral diabetes therapy].
    Bruneder H
    Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376
    [No Abstract]   [Full Text] [Related]  

  • 25. Treating type 2 diabetes: targeting the many causative factors.
    Sutherland JE; Hoehns JD
    J Fam Pract; 2004 May; 53(5):376-88. PubMed ID: 15125823
    [No Abstract]   [Full Text] [Related]  

  • 26. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of NIDDM.
    Kabadi UM
    J Fam Pract; 1992 Jan; 34(1):25. PubMed ID: 1728649
    [No Abstract]   [Full Text] [Related]  

  • 28. The management of non-insulin-dependent diabetes mellitus in the elderly.
    Ruoff G
    J Fam Pract; 1993 Mar; 36(3):329-35. PubMed ID: 8454981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sulfonylureas].
    Sagreira L
    Acta Med Port; 1989 Sep; Suppl 1():9S-13S. PubMed ID: 2694782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination therapy for type 2 diabetes.
    Bell DS
    Am Fam Physician; 2001 Dec; 64(11):1812, 1814. PubMed ID: 11764861
    [No Abstract]   [Full Text] [Related]  

  • 31. [The importance of concurrent therapy with insulin and sulfonylurea derivatives in type II diabetes].
    Podrouzková B
    Vnitr Lek; 1994 May; 40(5):310-2. PubMed ID: 8023473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drugs for type 2 diabetes.
    Treat Guidel Med Lett; 2008 Jul; 6(71):47-54. PubMed ID: 18583949
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.
    Bressler R; Johnson DG
    Arch Intern Med; 1997 Apr; 157(8):836-48. PubMed ID: 9129543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin: either alone or combined with oral hypoglycemic agents.
    Firth RG
    Prim Care; 1988 Sep; 15(3):665-83. PubMed ID: 3054969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why insulin sensitizers but not secretagogues should be retained when initiating insulin in type 2 diabetes.
    Raskin P
    Diabetes Metab Res Rev; 2008; 24(1):3-13. PubMed ID: 17968971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy.
    Bell DS
    Clin Ther; 2004 Nov; 26(11):1714-27. PubMed ID: 15639686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination insulin-sulfonylurea therapy in type II diabetes mellitus.
    Allen BT; Feinglos MN
    South Med J; 1987 Oct; 80(10):1285-9. PubMed ID: 3310252
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H; Miller JL; Rose LI
    Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary failure to sulfonylureas in NIDDM. Are sulfonylureas still useful?
    Menon KN; Seshadri MS
    J Assoc Physicians India; 1990 Aug; 38(8):533-4. PubMed ID: 2123182
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of sulphonylurea therapy on in vivo insulin sensitivity in non-insulin dependent diabetics.
    Ponchner M; Taylor R; Heine R; Alberti KG
    Horm Metab Res; 1984 Apr; 16(4):208. PubMed ID: 6373546
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.